The initial side effects of Wegovy: deciding how to respond

What your body is doing in the first few weeks

Semaglutide works by activating GLP-1 receptors in the gut and brain, slowing how quickly food moves through your stomach and reducing appetite signals. That mechanism is exactly why Wegovy helps with weight loss, and exactly why the initial side effects of Wegovy cluster around the digestive system. Nausea is the headline complaint, but people also commonly report loose stools or constipation, burping, indigestion, and occasional vomiting. Fatigue and headaches show up in some people too, particularly in the early weeks.

These effects are not a sign that something has gone wrong. They reflect your gut adapting to a medicine that is genuinely changing the speed and character of digestion. For most people they are most noticeable in the 24 to 48 hours after an injection, then fade. Keeping your pen in the fridge door next to something you open every morning can help build the habit of a consistent injection day, which matters because irregular timing can make GI symptoms less predictable.

The starting dose of 0.25 mg exists precisely to give your system time to adjust before the dose climbs. Most people find the nausea is manageable at that level even when it returns at each increase. Eating smaller portions, avoiding fatty or spicy food, and staying well hydrated all reduce the burden, practical steps your prescriber will go through with you.

The side effects that should not be waited out

Knowing when an initial side effect of Wegovy crosses into something that needs same-day medical attention is the more important question. There are a few clear signals.

Severe, persistent abdominal pain (particularly pain that spreads into your back, with or without vomiting) needs urgent assessment. In January 2026 the MHRA issued a Drug Safety Update highlighting acute pancreatitis as a known, infrequent but serious risk with GLP-1 medicines; the specific symptom pattern to act on is that radiating pain. You can find the full safety communication in the MHRA Drug Safety Update archive. This is not common, but it is not the kind of symptom to monitor at home.

Signs of a serious allergic reaction (swelling of the face or throat, difficulty breathing, a widespread rash) also need 999 or immediate emergency care. Symptoms of significant dehydration from repeated vomiting or diarrhoea, such as dizziness, very dark urine or confusion, warrant a call to NHS 111 rather than waiting. If you develop right-sided abdominal pain and fever suggesting a gallbladder problem, seek medical advice the same day.

For a fuller picture of the complete side-effect profile across the treatment period, our Wegovy side effects guide covers what the clinical trial data shows beyond the initial weeks. The more serious adverse effects page goes into the rarer end of the spectrum in more detail.

Deciding whether to push through or pause

This is the real decision most people face around weeks two to four: the side effects are unpleasant enough to be disheartening, but not dangerous. Stopping prematurely is common, and often unnecessary.

A few things are worth weighing. First, nausea that is bad enough to stop you eating or drinking properly is different from nausea that is uncomfortable but tolerable. If you cannot keep fluids down, contact your prescriber or a GP rather than continuing unaided. Second, if your side effects are persisting well beyond two weeks at a stable dose with no sign of settling, that is worth discussing, it sometimes points to a slower titration being more appropriate for you.

Third, side effects that were manageable at one dose and became severe after an increase may resolve if the prescriber holds the current dose a little longer before moving up. The titration schedule exists as guidance; it is not a fixed clock. Our guide to potential Wegovy side effects has more on how dose progression interacts with tolerability, and the FAQs page addresses some of the most common practical questions people bring to consultation.

If you are weighing up whether Wegovy might be appropriate for your situation, our prescribers talk through side effects and individual suitability as part of the free consultation, there is no commitment involved. You can find out more about the Wegovy treatment page or explore all weight-loss treatment options we offer.

Reporting a side effect and getting ongoing support

Wegovy carries a Black Triangle (▼) designation, meaning it is subject to additional monitoring by the MHRA. That is not a concern about the medicine's safety record; it is standard practice for newer medicines and means reports of side effects are especially valuable. If you experience something unexpected (whether or not you think it is related to Wegovy) you can report it via the Yellow Card scheme, and so can your prescriber.

Ongoing clinical support matters as much as the initial assessment. At nume, our prescribers and aftercare team are reachable seven days a week for exactly these moments. If something does not feel right, that is what we are there for. You can also read more about the full side-effect record for Wegovy or see individual side effect profiles if a specific symptom is what brought you here. Our about us page explains the clinical oversight behind every prescription we issue.